Icandra (previously Vildagliptin / metformin hydrochloride Novartis) האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Neparvis האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - hjertefeil - agenter som virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Zomarist האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Remeron-S 30 mg נורווגיה - נורבגית - Statens legemiddelverk

remeron-s 30 mg

n.v. organon - kloosterstraat - mirtazapin - smeltetablett - 30 mg

Remeron-S 15 mg נורווגיה - נורבגית - Statens legemiddelverk

remeron-s 15 mg

n.v. organon - kloosterstraat - mirtazapin - smeltetablett - 15 mg

Remeron-S 45 mg נורווגיה - נורבגית - Statens legemiddelverk

remeron-s 45 mg

n.v. organon - kloosterstraat - mirtazapin - smeltetablett - 45 mg

Zerbaxa האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

zerbaxa

merck sharp & dohme b.v.  - ceftolozane sulfat, tazobactam sodium - bakterielle infeksjoner - antibakterielle midler for systemisk bruk, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Pirfenidone axunio (previously Pirfenidone AET) האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

pirfenidone axunio (previously pirfenidone aet)

axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Dipeptiven 200 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

dipeptiven 200 mg/ ml

fresenius kabi norge as - halden - alanylglutamin - konsentrat til infusjonsvæske, oppløsning - 200 mg/ ml

Plenvu נורווגיה - נורבגית - Statens legemiddelverk

plenvu

norgine b.v. - makrogol 3350 / natriumaskorbat / natriumsulfat, vannfritt / askorbinsyre / natriumklorid / kaliumklorid - pulver til mikstur, oppløsning - 140 g / 48.11 g / 9 g / 7.54 g / 5.2 g / 2.2 g